CHG-2024-0117

New Dosage Strength for Lecanemabix. Specification Change for Lecanemabix — major revision. Impacts 8 markets and 2 variations.

Change Number
CHG-2024-0117
Type
New Dosage Strength
Product
Lecanemabix
Status
Approved
Owner
Carlos Mendez
Initiated
2022-10-02
Description

Specification Change for Lecanemabix — major revision

Impacted Markets (8)
CN — ChinaGB — United KingdomCH — SwitzerlandFR — FranceIT — ItalySG — SingaporeAR — ArgentinaBE — Belgium
Impacted Modules
3.2.P2.3.P5.3.5
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved